Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1938 1
1939 1
1947 4
1948 1
1949 1
1951 6
1952 7
1953 9
1954 5
1955 3
1956 3
1957 7
1958 3
1959 5
1960 4
1961 1
1962 5
1963 3
1964 5
1965 1
1966 2
1967 2
1968 2
1969 4
1970 5
1971 2
1972 4
1973 7
1974 3
1975 3
1976 3
1977 6
1978 1
1982 1
1983 4
1984 4
1985 3
1986 5
1987 8
1988 7
1989 11
1990 8
1991 8
1992 9
1993 12
1994 14
1995 15
1996 27
1997 11
1998 18
1999 20
2000 28
2001 32
2002 24
2003 25
2004 23
2005 23
2006 33
2007 31
2008 32
2009 30
2010 47
2011 54
2012 39
2013 50
2014 51
2015 67
2016 58
2017 65
2018 68
2019 68
2020 80
2021 90
2022 82
2023 92
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

1,365 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Tam CS, Allan JN, Siddiqi T, Kipps TJ, Jacobs R, Opat S, Barr PM, Tedeschi A, Trentin L, Bannerji R, Jackson S, Kuss BJ, Moreno C, Szafer-Glusman E, Russell K, Zhou C, Ninomoto J, Dean JP, Wierda WG, Ghia P. Tam CS, et al. Among authors: russell k. Blood. 2022 Jun 2;139(22):3278-3289. doi: 10.1182/blood.2021014488. Blood. 2022. PMID: 35196370 Free PMC article.
Genome Sequencing for Diagnosing Rare Diseases.
Wojcik MH, Lemire G, Berger E, Zaki MS, Wissmann M, Win W, White SM, Weisburd B, Wieczorek D, Waddell LB, Verboon JM, VanNoy GE, Töpf A, Tan TY, Syrbe S, Strehlow V, Straub V, Stenton SL, Snow H, Singer-Berk M, Silver J, Shril S, Seaby EG, Schneider R, Sankaran VG, Sanchis-Juan A, Russell KA, Reinson K, Ravenscroft G, Radtke M, Popp D, Polster T, Platzer K, Pierce EA, Place EM, Pajusalu S, Pais L, Õunap K, Osei-Owusu I, Opperman H, Okur V, Oja KT, O'Leary M, O'Heir E, Morel CF, Merkenschlager A, Marchant RG, Mangilog BE, Madden JA, MacArthur D, Lovgren A, Lerner-Ellis JP, Lin J, Laing N, Hildebrandt F, Hentschel J, Groopman E, Goodrich J, Gleeson JG, Ghaoui R, Genetti CA, Gburek-Augustat J, Gazda HT, Ganesh VS, Ganapathi M, Gallacher L, Fu JM, Evangelista E, England E, Donkervoort S, DiTroia S, Cooper ST, Chung WK, Christodoulou J, Chao KR, Cato LD, Bujakowska KM, Bryen SJ, Brand H, Bönnemann CG, Beggs AH, Baxter SM, Bartolomaeus T, Agrawal PB, Talkowski M, Austin-Tse C, Abou Jamra R, Rehm HL, O'Donnell-Luria A. Wojcik MH, et al. Among authors: russell ka. N Engl J Med. 2024 Jun 6;390(21):1985-1997. doi: 10.1056/NEJMoa2314761. N Engl J Med. 2024. PMID: 38838312
Reply.
Ellis MJ, Ritchie L, McDonald P, Russell K. Ellis MJ, et al. Among authors: russell k. Clin J Sport Med. 2018 Nov;28(6):e99-e101. doi: 10.1097/JSM.0000000000000490. Clin J Sport Med. 2018. PMID: 28976404 No abstract available.
Reply to Willoughby.
Holzbauer SM, Schrodt CA, Prabhu RM, Asch-Kendrick RJ, Ireland M, Klumb C, Firestone MJ, Liu G, Harry K, Levine MZ, Orciari LA, Wilkins K, Ellison JA, Zhao H, Niezgoda M, Satheshkumar PS, Petersen BW, Rao AK, Bell WR, Forrest S, Gao W, Dasheiff R, Russell K, Wiseman A, Reichard RR, Smith KE, Lynfield R, Scheftel J, Wallace RM, Bonwitt J. Holzbauer SM, et al. Among authors: russell k. Clin Infect Dis. 2023 Sep 18;77(6):931-932. doi: 10.1093/cid/ciad295. Clin Infect Dis. 2023. PMID: 37200504 Free PMC article. No abstract available.
Somethings Old with Somethings New.
Heatley JJ, Russell KE. Heatley JJ, et al. Among authors: russell ke. Vet Clin North Am Exot Anim Pract. 2022 Sep;25(3):xiii-xiv. doi: 10.1016/j.cvex.2022.07.001. Vet Clin North Am Exot Anim Pract. 2022. PMID: 36122953 No abstract available.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, Satoh H, Mourani C, Ariceta G, Torres A, Wolley M, Belostotsky V, Forbes TA, Groothoff J, Hayes W, Tönshoff B, Takayama T, Rosskamp R, Russell K, Zhou J, Amrite A, Hoppe B; PHYOX2 study investigators. Baum MA, et al. Among authors: russell k. Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22. Kidney Int. 2023. PMID: 36007597 Free article. Clinical Trial.
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.
Mascia AE, Daugherty EC, Zhang Y, Lee E, Xiao Z, Sertorio M, Woo J, Backus LR, McDonald JM, McCann C, Russell K, Levine L, Sharma RA, Khuntia D, Bradley JD, Simone CB 2nd, Perentesis JP, Breneman JC. Mascia AE, et al. Among authors: russell k. JAMA Oncol. 2023 Jan 1;9(1):62-69. doi: 10.1001/jamaoncol.2022.5843. JAMA Oncol. 2023. PMID: 36273324 Free PMC article.
1,365 results